Miach Orthopaedics Raises $20M in Series B Extension
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Stay updated with breaking news from Patrick Mcbrayer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Miach Orthopaedics Inc. has announced the closing of a $40 million financing round to expand commercialization of the bridge-enhanced ACL restoration implant in the United States, according to a company press release. Financing for expanded commercialization of the bridge-enhanced ACL restoration (BEAR) implant was provided by equity from the following investors: Sectoral Asset
Miach Orthopaedics — a medical device company focused on restoring torn ACLs instead of reconstructing them — recently received $40 million in funding. The capital will be used to expand the U.S. commercial rollout of the company's implantable device, which received FDA de novo clearance in 2020.
Miach Orthopaedics closed on $40 million in financing to support expanded U.S. commercialization of its Bear implant to treat ACL tears.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!